WellGen is currently seeking $4 million to launch our consumer sports beverage, complete pre-clinical studies, and conduct two small, proof-of-principle clinical trials for osteoarthritis and diabetes.
North Brunswick, NJ–(BUSINESS WIRE)—WellGen, Inc. (www.wellgen.com), a private biotechnology company that is discovering and developing proprietary medical foods using nutrigenomics technology, announced that Dr. Roddy Carter, president and chief executive officer, will present [...]
Continue Reading...